Budenofalk 2 mg rectal foam represents a major new option in the treatment of patients with ulcerous colitis

Abstract

The article provides information on rectal foam containing budesonide with regard to its pharmacokinetic and pharmacodynamic properties, therapeutic indication, efficacy and safety. Furthermore, a short overview about local therapy of ulcerative colitis is given.

Keywords

• budesonide
• ulcerative colitis
• local therapy